Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01842763
Other study ID # 12-PP-08
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 2013
Est. completion date January 2028

Study information

Verified date February 2024
Source Centre Hospitalier Universitaire de Nice
Contact Michel LANTERI-MINET, Dr
Phone 04 92 03 79 46
Email lanteri-minet.m@chu-nice.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this non interventional research is to set up a French database, initially for 3 years, of patients suffering from refractory chronic headache disorders (chronic migraine, cluster headache, chronic paroxysmal hemicranias, SUNCT syndrome, hemicrania continua, cervicogenic headache disorders), and treated by occipital nerves stimulation. Every team using this neuromodulation approach in France is likely to participate in the network. Fifty patients a year are expected. They will be informed about data which are collected and why they are collected. The data will come from medical files and questionnaires filling out by the patients. The data will be collected on a case report form adapted to each refractory chronic headache disorder. The case report form pages will be faxed to the coordinating team who will enter the data in the database and analyse the data in a descriptive manner. These data are social and demographic data, medical data (headache features, headache functional and emotional impact, medications, and concomitant medical conditions), technical data (kind of electrodes and implantable pulse generator used, stimulation parameters chosen), and safety data. This research should provide an update on practices, an evaluation of the efficacy and long term safety of occipital nerves stimulation, and perhaps help in identifying response predictive factors to this neuromodulation approach.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date January 2028
Est. primary completion date January 2028
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients suffering from refractory chronic headache disorders and treated by occipital nerves stimulation Exclusion Criteria: - patients who don't agree with participating in the study because the ending of professional confidentiality is required for setting up the database

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Clermont Ferrand CHU Clermont-Ferrand
France Hopitaux Civil de Colmar Colmar Haut-rhin
France Annecy Genevois CHU Épagny
France Grenoble CHU Grenoble
France Lille CHU Lille
France Limoges CHU Limoges
France HCL Lyon
France APHM Marseille
France Nancy CHU Nancy
France Nantes CHU Nantes
France Département d'Evaluation et Traitement de la Douleur Nice
France Adolphe de Rothschild Foundation Paris
France AP-HP Lariboisière Paris
France Poitiers CHU Poitiers
France Saint Etienne CHU Saint-Étienne
France Foch Hospital Suresnes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary observation of a disease or medical condition under normal conditions social and demographic data, medical data (headache features, headache functional and emotional impact, medications, and concomitant medical conditions), technical data (kind of electrodes and implantable pulse generator used, stimulation parameters chosen), and safety data. at each visit (up to 4 years)